MaxCmin1: first head-to-head comparison of boosted PIs

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1315, 2001-01, pp. : 17-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lopinavir/ritonavir vs saquinavir/ritonavir: the MaxCmin2 results

By  

Inpharma, Vol. 1, Iss. 1518, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Head-To-Head Comparison of the Costs of Atypical Antipsychotics: A Systematic Review

By Barbui Corrado  

CNS Drugs, Vol. 19, Iss. 11, 2005-01 ,pp. : 935-950

Adis International

Access to resources Recommend Favorite

Post-Hoc Analysis of a Head-to-Head Hyaluronic Acid Comparison in Knee Osteoarthritis Using the 2004 OMERACT-OARSI Responder Criteria

By Onel Erol  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 37-45

Adis International

Access to resources Recommend Favorite

No Head-to-Head Trial? Simulate the Missing Arms

By Caro J. Jaime   Ishak K. Jack  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 957-967

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Without Head-to-Head Trials: A Method for Matching-Adjusted Indirect Comparisons Applied to Psoriasis Treatment with Adalimumab or Etanercept

By Signorovitch James E.  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 935-945

Adis International

Access to resources Recommend Favorite